Found: 114
Select item for more details and to access through your institution.
Kinetics of the hepatitis B core‐related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 993, doi. 10.1111/hepr.14052
- By:
- Publication type:
- Article
Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 5, p. N.PAG, doi. 10.1093/ofid/ofz185
- By:
- Publication type:
- Article
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
- By:
- Publication type:
- Article
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11431-1
- By:
- Publication type:
- Article
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 269, doi. 10.1007/s40121-020-00364-9
- By:
- Publication type:
- Article
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 851, doi. 10.1007/s40121-020-00329-y
- By:
- Publication type:
- Article
Assessment of Ultra-Early-Stage Liver Fibrosis in Human Non-Alcoholic Fatty Liver Disease by Second-Harmonic Generation Microscopy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3357, doi. 10.3390/ijms23063357
- By:
- Publication type:
- Article
Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study.
- Published in:
- Journal of Medical Virology, 2013, v. 85, n. 1, p. 65, doi. 10.1002/jmv.23428
- By:
- Publication type:
- Article
Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5-year study of patients with hepatitis B with lamivudine resistance.
- Published in:
- Journal of Medical Virology, 2012, v. 84, n. 10, p. 1562, doi. 10.1002/jmv.23371
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
- By:
- Publication type:
- Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
- By:
- Publication type:
- Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
- By:
- Publication type:
- Article
Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 506, doi. 10.1159/000480139
- By:
- Publication type:
- Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
- By:
- Publication type:
- Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 172, doi. 10.1111/hepr.13845
- By:
- Publication type:
- Article
Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 51, doi. 10.1111/hepr.13840
- By:
- Publication type:
- Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
- By:
- Publication type:
- Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug‐induced liver injury.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1047, doi. 10.1111/hepr.13532
- By:
- Publication type:
- Article
Clinical outcomes of hepatitis C virus elimination using glecaprevir and pibrentasvir in hemodialysis patients: A multicenter study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 5, p. 557, doi. 10.1111/hepr.13482
- By:
- Publication type:
- Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
- By:
- Publication type:
- Article
Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1365, doi. 10.1111/hepr.13410
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.
- Published in:
- Hepatology Research, 2019, v. 49, n. 4, p. 369, doi. 10.1111/hepr.13292
- By:
- Publication type:
- Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
- By:
- Publication type:
- Article
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial.
- Published in:
- Hepatology Research, 2018, v. 48, n. 6, p. 411, doi. 10.1111/hepr.13045
- By:
- Publication type:
- Article
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1308, doi. 10.1111/hepr.12898
- By:
- Publication type:
- Article
Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.
- Published in:
- Hepatology Research, 2016, v. 46, n. 8, p. 734, doi. 10.1111/hepr.12613
- By:
- Publication type:
- Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
- Published in:
- Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
- By:
- Publication type:
- Article
Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype.
- Published in:
- Hepatology Research, 2015, v. 45, n. 4, p. 387, doi. 10.1111/hepr.12360
- By:
- Publication type:
- Article
A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study.
- Published in:
- Hepatology Research, 2014, v. 44, n. 14, p. E386, doi. 10.1111/hepr.12323
- By:
- Publication type:
- Article
Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load.
- Published in:
- Hepatology Research, 2014, v. 44, n. 10, p. E257, doi. 10.1111/hepr.12207
- By:
- Publication type:
- Article
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2014, v. 44, n. 3, p. 296, doi. 10.1111/hepr.12123
- By:
- Publication type:
- Article
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial.
- Published in:
- Hepatology Research, 2014, v. 44, n. 1, p. 73, doi. 10.1111/hepr.12098
- By:
- Publication type:
- Article
Effects of branched-chain amino acid granules on serum albumin level and prognosis are dependent on treatment adherence in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2013, v. 43, n. 5, p. 459, doi. 10.1111/j.1872-034X.2012.01097.x
- By:
- Publication type:
- Article
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C S. Kaneko et al. DFPP increases cEVR rates of interferon therapy.
- Published in:
- Hepatology Research, 2010, v. 40, n. 11, p. 1072, doi. 10.1111/j.1872-034X.2010.00708.x
- By:
- Publication type:
- Article
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
- Published in:
- BMC Infectious Diseases, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2334-12-324
- By:
- Publication type:
- Article
Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
- By:
- Publication type:
- Article
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3243, doi. 10.3390/cancers15123243
- By:
- Publication type:
- Article
Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4605, doi. 10.3390/cancers13184605
- By:
- Publication type:
- Article
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2257, doi. 10.3390/cancers13092257
- By:
- Publication type:
- Article
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257166
- By:
- Publication type:
- Article